HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[3H]raclopride binding to brain tissue from subjects with schizophrenia: methodological aspects.

Abstract
The binding of [3H]raclopride to particulate membrane and frozen sections (with quantitative autoradiography) from the caudate-putamen, obtained at autopsy from schizophrenic and non-schizophrenic subjects, was measured. The affinity of [3H]raclopride to particulate membrane was significantly decreased in the schizophrenic compared to non-schizophrenic subjects. The density of [3H]raclopride binding to tissue from subjects with schizophrenia was increased, unchanged or decreased depending on the methodology used. Finally, there was an age-dependent decrease in [3H]raclopride binding in the frozen sections from the caudate-putamen of the non-schizophrenic subjects. This age-dependent decrease was not apparent using particulate membrane from schizophrenic or non-schizophrenic subjects or tissue sections from the schizophrenic subjects. We conclude that the binding of [3H]raclopride is dependent on methodology and therefore data from in vitro and in vivo studies using this drug should be interpreted with caution.
AuthorsB Dean, G Pavey, K Opeskin
JournalNeuropharmacology (Neuropharmacology) Vol. 36 Issue 6 Pg. 779-86 (Jun 1997) ISSN: 0028-3908 [Print] England
PMID9225305 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Dopamine Antagonists
  • Receptors, Dopamine D2
  • Salicylamides
  • Raclopride
Topics
  • Adult
  • Aged
  • Autoradiography
  • Brain (metabolism)
  • Caudate Nucleus (metabolism)
  • Cell Membrane (metabolism)
  • Dopamine Antagonists (metabolism)
  • Female
  • Humans
  • In Vitro Techniques
  • Male
  • Middle Aged
  • Protein Binding
  • Putamen (metabolism)
  • Raclopride
  • Receptors, Dopamine D2 (metabolism)
  • Salicylamides (metabolism)
  • Schizophrenia (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: